Expression of glutamate transporter, GABRA6, serine proteinase inhibitor 2 and low levels of glutamate and GABA in the brain of knock-out mouse for Canavan disease

Sankar Surendran, Peter L. Rady, Kimberlee Michals-Matalon, Michael J. Quast, David K. Rassin, Gerald Campbell, Ed L. Ezell, Jingna Wei, Stephen K. Tyring, Sylvia Szucs, Reuben Matalon

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Canavan disease (CD) is an autosomal recessive leukodystrophy characterized by spongy degeneration of the brain. The clinical features of CD are hypotonia, megalencephaly, and mental retardation leading to early death. While aspartoacylase (ASPA) activity increases with age in the wild type mouse brain, there is no ASPA activity in the CD mouse brain. So far ASPA deficiency and elevated NAA have been ascribed with the CD. Other factors affecting the brain that result from ASPA deficiency may lead pathophysiology of CD. The NMR spectra and amino acid analysis showed lower levels of glutamate and γ-aminobutyric acid in the CD mouse brain compared to the wild type. Microarray gene expression on CD mouse brain showed glutamate transporter-EAAT4 and γ-aminobutyric acid-A receptor, subunit α6 (GABRA6) were lower 9.7- and 119.1-fold, respectively. Serine proteinase inhibitor 2 (Spi2) was 29.9-fold higher in the CD mouse brain compared to the wild type. The decrease of GABRA6 and high expression of Spi2 in CD mouse brain were also confirmed by real-time RT-PCR. This first report showing abnormal expression of EAAT4, GABRA6, Spi2 combined with lower levels of glutamate and GABA are likely to be associated with the pathophysiology of CD.

Original languageEnglish (US)
Pages (from-to)427-435
Number of pages9
JournalBrain Research Bulletin
Volume61
Issue number4
DOIs
StatePublished - Aug 30 2003

Fingerprint

Canavan Disease
Amino Acid Transport System X-AG
Serine Proteinase Inhibitors
Knockout Mice
gamma-Aminobutyric Acid
Glutamic Acid
Brain
Aminobutyrates
Megalencephaly
Muscle Hypotonia

Keywords

  • Canavan disease
  • EAAT4
  • GABA
  • GABRA6
  • Glutamate
  • Spi2

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Expression of glutamate transporter, GABRA6, serine proteinase inhibitor 2 and low levels of glutamate and GABA in the brain of knock-out mouse for Canavan disease. / Surendran, Sankar; Rady, Peter L.; Michals-Matalon, Kimberlee; Quast, Michael J.; Rassin, David K.; Campbell, Gerald; Ezell, Ed L.; Wei, Jingna; Tyring, Stephen K.; Szucs, Sylvia; Matalon, Reuben.

In: Brain Research Bulletin, Vol. 61, No. 4, 30.08.2003, p. 427-435.

Research output: Contribution to journalArticle

Surendran, Sankar ; Rady, Peter L. ; Michals-Matalon, Kimberlee ; Quast, Michael J. ; Rassin, David K. ; Campbell, Gerald ; Ezell, Ed L. ; Wei, Jingna ; Tyring, Stephen K. ; Szucs, Sylvia ; Matalon, Reuben. / Expression of glutamate transporter, GABRA6, serine proteinase inhibitor 2 and low levels of glutamate and GABA in the brain of knock-out mouse for Canavan disease. In: Brain Research Bulletin. 2003 ; Vol. 61, No. 4. pp. 427-435.
@article{955056edced34eb9924607fa2c79d628,
title = "Expression of glutamate transporter, GABRA6, serine proteinase inhibitor 2 and low levels of glutamate and GABA in the brain of knock-out mouse for Canavan disease",
abstract = "Canavan disease (CD) is an autosomal recessive leukodystrophy characterized by spongy degeneration of the brain. The clinical features of CD are hypotonia, megalencephaly, and mental retardation leading to early death. While aspartoacylase (ASPA) activity increases with age in the wild type mouse brain, there is no ASPA activity in the CD mouse brain. So far ASPA deficiency and elevated NAA have been ascribed with the CD. Other factors affecting the brain that result from ASPA deficiency may lead pathophysiology of CD. The NMR spectra and amino acid analysis showed lower levels of glutamate and γ-aminobutyric acid in the CD mouse brain compared to the wild type. Microarray gene expression on CD mouse brain showed glutamate transporter-EAAT4 and γ-aminobutyric acid-A receptor, subunit α6 (GABRA6) were lower 9.7- and 119.1-fold, respectively. Serine proteinase inhibitor 2 (Spi2) was 29.9-fold higher in the CD mouse brain compared to the wild type. The decrease of GABRA6 and high expression of Spi2 in CD mouse brain were also confirmed by real-time RT-PCR. This first report showing abnormal expression of EAAT4, GABRA6, Spi2 combined with lower levels of glutamate and GABA are likely to be associated with the pathophysiology of CD.",
keywords = "Canavan disease, EAAT4, GABA, GABRA6, Glutamate, Spi2",
author = "Sankar Surendran and Rady, {Peter L.} and Kimberlee Michals-Matalon and Quast, {Michael J.} and Rassin, {David K.} and Gerald Campbell and Ezell, {Ed L.} and Jingna Wei and Tyring, {Stephen K.} and Sylvia Szucs and Reuben Matalon",
year = "2003",
month = "8",
day = "30",
doi = "10.1016/S0361-9230(03)00158-8",
language = "English (US)",
volume = "61",
pages = "427--435",
journal = "Brain Research Bulletin",
issn = "0361-9230",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Expression of glutamate transporter, GABRA6, serine proteinase inhibitor 2 and low levels of glutamate and GABA in the brain of knock-out mouse for Canavan disease

AU - Surendran, Sankar

AU - Rady, Peter L.

AU - Michals-Matalon, Kimberlee

AU - Quast, Michael J.

AU - Rassin, David K.

AU - Campbell, Gerald

AU - Ezell, Ed L.

AU - Wei, Jingna

AU - Tyring, Stephen K.

AU - Szucs, Sylvia

AU - Matalon, Reuben

PY - 2003/8/30

Y1 - 2003/8/30

N2 - Canavan disease (CD) is an autosomal recessive leukodystrophy characterized by spongy degeneration of the brain. The clinical features of CD are hypotonia, megalencephaly, and mental retardation leading to early death. While aspartoacylase (ASPA) activity increases with age in the wild type mouse brain, there is no ASPA activity in the CD mouse brain. So far ASPA deficiency and elevated NAA have been ascribed with the CD. Other factors affecting the brain that result from ASPA deficiency may lead pathophysiology of CD. The NMR spectra and amino acid analysis showed lower levels of glutamate and γ-aminobutyric acid in the CD mouse brain compared to the wild type. Microarray gene expression on CD mouse brain showed glutamate transporter-EAAT4 and γ-aminobutyric acid-A receptor, subunit α6 (GABRA6) were lower 9.7- and 119.1-fold, respectively. Serine proteinase inhibitor 2 (Spi2) was 29.9-fold higher in the CD mouse brain compared to the wild type. The decrease of GABRA6 and high expression of Spi2 in CD mouse brain were also confirmed by real-time RT-PCR. This first report showing abnormal expression of EAAT4, GABRA6, Spi2 combined with lower levels of glutamate and GABA are likely to be associated with the pathophysiology of CD.

AB - Canavan disease (CD) is an autosomal recessive leukodystrophy characterized by spongy degeneration of the brain. The clinical features of CD are hypotonia, megalencephaly, and mental retardation leading to early death. While aspartoacylase (ASPA) activity increases with age in the wild type mouse brain, there is no ASPA activity in the CD mouse brain. So far ASPA deficiency and elevated NAA have been ascribed with the CD. Other factors affecting the brain that result from ASPA deficiency may lead pathophysiology of CD. The NMR spectra and amino acid analysis showed lower levels of glutamate and γ-aminobutyric acid in the CD mouse brain compared to the wild type. Microarray gene expression on CD mouse brain showed glutamate transporter-EAAT4 and γ-aminobutyric acid-A receptor, subunit α6 (GABRA6) were lower 9.7- and 119.1-fold, respectively. Serine proteinase inhibitor 2 (Spi2) was 29.9-fold higher in the CD mouse brain compared to the wild type. The decrease of GABRA6 and high expression of Spi2 in CD mouse brain were also confirmed by real-time RT-PCR. This first report showing abnormal expression of EAAT4, GABRA6, Spi2 combined with lower levels of glutamate and GABA are likely to be associated with the pathophysiology of CD.

KW - Canavan disease

KW - EAAT4

KW - GABA

KW - GABRA6

KW - Glutamate

KW - Spi2

UR - http://www.scopus.com/inward/record.url?scp=0042165900&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042165900&partnerID=8YFLogxK

U2 - 10.1016/S0361-9230(03)00158-8

DO - 10.1016/S0361-9230(03)00158-8

M3 - Article

VL - 61

SP - 427

EP - 435

JO - Brain Research Bulletin

JF - Brain Research Bulletin

SN - 0361-9230

IS - 4

ER -